Mima, A., & Horii, Y. (2024). Tirzepatide Reduces Fat Mass and Provides Good Glycaemic Control in Type 2 Diabetes Patients Undergoing Haemodialysis: A Single‐Centre Retrospective Study. Wiley. https://doi.org/10.1002/edm2.489
Chicago-Zitierstil (17. Ausg.)Mima, Akira, und Yasuhiro Horii. Tirzepatide Reduces Fat Mass and Provides Good Glycaemic Control in Type 2 Diabetes Patients Undergoing Haemodialysis: A Single‐Centre Retrospective Study. Wiley, 2024. https://doi.org/10.1002/edm2.489.
MLA-Zitierstil (9. Ausg.)Mima, Akira, und Yasuhiro Horii. Tirzepatide Reduces Fat Mass and Provides Good Glycaemic Control in Type 2 Diabetes Patients Undergoing Haemodialysis: A Single‐Centre Retrospective Study. Wiley, 2024. https://doi.org/10.1002/edm2.489.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.